Based on a preceding report describing the anti-inflammatory action of maltol [24], this study suggests that maltol could potentially exert a protective mechanism against APAP liver toxicity that might be partly attributed to the blockade of NF-κB signal activation. The gene discussed is NFKB1; the disease is toxicity.